T1	Concept 0 6	People
T2	Concept 12 25	blood group A
R1	has-property Arg1:T1 Arg2:T2	
T6	Concept 232 247	school closures
T7	Concept 278 296	COVID-19 outbreaks
T8	Concept 324 343;344 349	levels of prevented cases
T10	Concept 267 274	earlier
T11	Action 255 266	implemented
R5	target Arg1:T11 Arg2:T6	
R4	in-time Arg1:T11 Arg2:T7	
R6	in-context Arg1:T11 Arg2:T10	
R7	entails Arg1:T11 Arg2:T8	
T12	Action 308 312	lead
A2	Uncertain T12
R8	subject Arg1:T11 Arg2:T12	
R9	target Arg1:T12 Arg2:T8	
T14	Action 393 401	believed
T15	Concept 411 422	flu vaccine
T16	Concept 465 480	COVID-19 spread
T18	Concept 497 504	persons
T19	Concept 517 525	symptoms
A3	Negated T19
R10	has-property Arg1:T18 Arg2:T19	
T20	Concept 529 548	clinically negative
T21	Concept 552 561	infection
R11	has-property Arg1:T18 Arg2:T20	
T17	Action 562 565;572 578	can spread
R12	subject Arg1:T17 Arg2:T18	
T23	Concept 645 653	COVID-19
T25	Concept 671 691	respiratory droplets
T28	Concept 824 836	environments
T29	Concept 811 823	contaminated
R15	has-property Arg1:T28 Arg2:T29	
T26	Concept 702 709	contact
T30	Concept 696 701	close
R16	has-property Arg1:T26 Arg2:T30	
T27	Concept 798 805	contact
T31	Concept 789 797	indirect
R17	has-property Arg1:T27 Arg2:T31	
T32	Concept 841 849	aerosols
T33	Concept 729 741	limited data
T34	Action 774 780	spread
A4	Emphasized T8
T9	Action 486 491	shows
R2	subject Arg1:T9 Arg2:T16	
T35	Concept 465 473	COVID-19
R13	target Arg1:T17 Arg2:T35	
R14	target Arg1:T9 Arg2:T17	
T4	Concept 124 137	blood group O
T13	Concept 371 392	allied health workers
R18	subject Arg1:T14 Arg2:T13	
T22	Action 423 436	is sufficient
T37	Concept 441 460	COVID-19 prevention
R19	subject Arg1:T22 Arg2:T15	
R20	target Arg1:T22 Arg2:T37	
R21	target Arg1:T14 Arg2:T22	
T38	Action 747 756	indicates
R22	subject Arg1:T34 Arg2:T23	
R23	in-context Arg1:T34 Arg2:T27	
R26	target Arg1:T38 Arg2:T34	
R27	subject Arg1:T38 Arg2:T33	
T39	Concept 364 367	20%
R28	in-context Arg1:T13 Arg2:T39	
A5	Uncertain T34
T24	Concept 624 641	transmission mode
T40	Concept 616 623	primary
R29	has-property Arg1:T24 Arg2:T40	
R30	is-a Arg1:T25 Arg2:T24	
R31	is-a Arg1:T26 Arg2:T24	
R32	in-context Arg1:T25 Arg2:T23	
R33	in-context Arg1:T26 Arg2:T23	
R24	in-context Arg1:T27 Arg2:T28	
R25	in-context Arg1:T27 Arg2:T32	
T5	Action 63 72	acquiring
T41	Concept 73 81	COVID-19
R3	target Arg1:T5 Arg2:T41	
T36	Concept 201 219	non-O blood groups
T42	Action 158 163	lower
R36	subject Arg1:T42 Arg2:T4	
R37	target Arg1:T42 Arg2:T36	
R38	in-context Arg1:T42 Arg2:T5	
T3	Action 47 53	higher
T43	Concept 96 114	non-A blood groups
R34	subject Arg1:T3 Arg2:T1	
R35	target Arg1:T3 Arg2:T43	
R39	in-context Arg1:T3 Arg2:T5	
